top of page
Nivolumab with Chemotherapy in Early ER+ Breast Cancer
What was the trial about? Doctors tested whether adding nivolumab (an immunotherapy drug) to chemotherapy before surgery could help...
madelynrosem
Mar 261 min read
0 views
0 comments
NATALEE Clinical Trial: Ribociclib (Kisquali) reduces recurrence risk in early stage breast cancer
The NATALEE Clinical Trial recently released new data regarding the effectiveness of the CDK4/6 inhibitor Ribociclib (Kisquali) in the...
madelynrosem
Sep 15, 20242 min read
15 views
0 comments
All About Clinical Trials: Their importance in the advancement of breast cancer treatment and who should consider participating.
What are Clinical Trials? Clinical Trials are medical studies that evaluate the effectiveness of new treatments and their effects on...
madelynrosem
Sep 15, 20244 min read
3 views
0 comments
PHERGain: Some HER2+ Patients Don't Need Chemotherapy
The current standard of treatment for those with HER 2 +, early stage breast cancers is dual HER2 blockade (which means the combination...
madelynrosem
Aug 15, 20242 min read
2 views
0 comments
Antibody Drug Conjugate Targeting A New Protein, HER3, Shows Promise for Heavily Pre-Treated ER+ and TNBC (Triple Negative) Breast Cancers
Presented at the 2023 American Society of Clinical Oncology Meeting, Phase II Clinical Trial NCT04699630 showed promising results in...
madelynrosem
Aug 12, 20242 min read
1 view
0 comments
monarchE: Abemaciclib (a CDK4/6 Inhibitor) + Hormone Therapy for the Adjuvant (Post-Surgery) Treatment of HR+ HER2- High Risk Early Stage Breast Cancer
The clinical trial monarchE assessed the benefit of combining the CDK4/6 inhibitor abemaciclib (a type of targeted therapy) with hormone...
madelynrosem
Aug 12, 20242 min read
1 view
0 comments
bottom of page